Document is current
Any future updates will be listed below
-
Authors
Bonolo de Campos, Cecilia
McCabe, Chantal E.
Bruins, Laura A.
O’Brien, Daniel R.
Brown, Sochilt
Tschumper, Renee C.
Allmer, Cristine
Zhu, Yuan Xiao
Rabe, Kari G. https://orcid.org/0000-0002-7313-1875
Parikh, Sameer A. https://orcid.org/0000-0002-3221-7314
Kay, Neil E. https://orcid.org/0000-0002-5951-5055
Yan, Huihuang https://orcid.org/0000-0003-0756-2922
Cerhan, James R. https://orcid.org/0000-0002-7482-178X
Allan, John N.
Furman, Richard R. https://orcid.org/0000-0003-1677-7626
Weinberg, J. Brice
Brander, Danielle M.
Jelinek, Diane F.
Chesi, Marta https://orcid.org/0000-0002-4024-8225
Slager, Susan L. https://orcid.org/0000-0002-5173-4712
Braggio, Esteban https://orcid.org/0000-0003-3860-4830
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA235026, R01CA254951, R01CA235026, R01CA254951)
- License Information
-
More Information
Article History
Received: 24 September 2024
Revised: 26 November 2024
Accepted: 16 December 2024
First Online: 6 February 2025
Competing interests
: SAP: Research funding has been provided to the institution from Janssen, AstraZeneca, Merck, and Genentech for clinical studies in which SAP is a principal investigator. Honoraria has been provided to the institution from Pharmacyclics, Merck, AstraZeneca, Janssen, Genentech, Amgen, MingSight Pharmaceuticals, TG Therapeutics, Novalgen Limited, Kite Pharma, and AbbVie for SAP’s participation in consulting activities/advisory board meetings. NEK: Advisory Board for AbbVie, Astra Zeneca, Beigene, Behring, Boehringer Ingelheim Pharmaceuticals, Inc., Dava Oncology, Janssen, Juno Therapeutics, and Pharmacyclics. Data Safety Monitoring Committee for Agios Pharm, AstraZeneca, BMS – Celgene, and Dren Bio Janssen. Research funding from AbbVie, Acerta Pharma, Bristol Meyer Squib, Celgene, Genentech, Pharmacyclics, Sunesis, and Vincerx. JNA: Consulting: Abbvie, BeiGene, Genentech, Janssen, Pharmacyclics. Research: BeiGene, Genentech, Janssen. Honoraria: Abbvie, AstraZenenca, BeiGene, Genentech, Janssen, Pharmacyclics
